WHAT IS AREXVY & SAFETY INFO
What Is AREXVY?
What Is AREXVY?
AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people 60 years of age and older.
Important Safety Information
- You should not receive AREXVY if you are allergic to any of its ingredients
AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people 60 years of age and older.
AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people 60 years of age and older.
Important Safety Information
Important Safety Information - Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum.
- You should not receive AREXVY if you are allergic to any of its ingredients
- A study suggests an increased risk of Guillain-Barré syndrome after vaccination with AREXVY
- You should not receive AREXVY if you are allergic to any of its ingredients
- A study suggests an increased risk of Guillain-Barré syndrome after vaccination with AREXVY
- Fainting can happen after getting injectable vaccines, including AREXVY. Precautions should be taken to avoid injury due to fainting
- Some people with weakened immune systems may have reduced immune responses to AREXVY
- The most common side effects are injection site pain, fatigue, muscle pain, headache, and joint pain
- Vaccination with AREXVY may not result in protection of all vaccine recipients
- Ask your healthcare provider about the risks and benefits of AREXVY. Only a healthcare provider can decide if AREXVY is right for you
Please see full Prescribing Information.
